We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Tata Consultancy Services Ltd is a leading global IT services consulting and business solutions organization offering transformational as well as outsourcing services to global enterprises. It has a ...

Company has reported net profit after tax of Rs 12,444.00 Crore in latest quarter.The company’s top management includes Mr.N Chandrasekaran, Mr.K Krithivasan, Mr.N G Subramaniam, Ms.Aarthi Subramanian ...